US53630X2036
US53630X2036
Lipocine Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.976.677 | 11.198.144 | 82.3% |
| Cost of Revenue | 8.583.919 | 7.351.753 | 16.8% |
| Gross Profit | -6.607.242 | 3.846.391 | 271.8% |
| 3.764.137 | 5.001.426 | 24.7% | |
| Operating Income | -10.371.379 | -1.155.035 | 797.9% |
| Pretax Income | -9.627.305 | 9.033 | 106679.3% |
| Net Income Common Stockholders | -9.627.505 | 8.352 | 115371.9% |
| -- | -- | -- | |
| -- | -- | -- |